<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04429490</url>
  </required_header>
  <id_info>
    <org_study_id>PA20035</org_study_id>
    <nct_id>NCT04429490</nct_id>
  </id_info>
  <brief_title>Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma</brief_title>
  <acronym>PESTIPAC</acronym>
  <official_title>Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma : a Case Control Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreatic adenocarcinoma represents more than 90% of pancreatic neoplasms. Around 14000 new&#xD;
      cases of pancreatic adenocarcinoma are being diagnosed each year in France and about 8.6% in&#xD;
      Grand Est region. National incidence has doubled for men and tripled for women between 1982&#xD;
      and 2012. Pancreatic adenocarcinoma is the deadliest digestive cancer, with only 7 to 8% all&#xD;
      stages 5-year survival. It will become the second deadliest in Europe, behind&#xD;
      bronchopulmonary cancer.&#xD;
&#xD;
      Several risk factors have been identified such as diabetes, tobacco, chronic pancreatitis or&#xD;
      obesity. However, a mismatch exists between incidence forecasts and actual risk factors&#xD;
      knowledge. Several hypothesis plead for an environnemental cause.&#xD;
&#xD;
      Plant protection products oncogenetic effects are known and have been proved to be&#xD;
      responsible for tumors, including haematological malignancies. Its role in pancreatic&#xD;
      carcinogenesis is still poorly studied and show heterogeneous results. They do not allow to&#xD;
      conclude for causality. Organochlorines is a specific subset of plant protection product that&#xD;
      store in lipids during lifetime.&#xD;
&#xD;
      The aim is to study association between organochlorine concentration in adipose tissue with&#xD;
      pancreatic adenocarcinoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Unicentric prospective case control study comparing organochlorine levels including patients&#xD;
      diagnosed with a pancreatic adenocarcinoma undergoing a surgery allowing to collect an&#xD;
      adipose tissue sample (10g).&#xD;
&#xD;
      Controls are adults with no pancreatic cancer (excluded by a 6 months old computed tomography&#xD;
      excluding the probability of a pancreatic neoplasm), paired with cases upon age and body mass&#xD;
      index, with a scheduled surgical procedure allowing to collect an adipose tissue sample&#xD;
      without extending procedure length.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2020</start_date>
  <completion_date type="Anticipated">September 12, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 12, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adipose tissue organochlorine concentration</measure>
    <time_frame>Day 0</time_frame>
    <description>QuEChERS method to extract organochlorines Use of Agilent 7010 Detection limit : 10ng/g of adipose tissue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urine organochlorine concentration</measure>
    <time_frame>Day 0</time_frame>
    <description>Use of Agilent 7010 Detection limit : 0.1microg/L</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Carcinoma</condition>
  <condition>Pancreatic Ductal</condition>
  <arm_group>
    <arm_group_label>Group &quot;Cases&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with pancreatic adenocarcinoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group &quot;Controls&quot;</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients without pancreatic adenocarcinoma</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adipose tissue sampling during surgery and urine sampling</intervention_name>
    <description>Adipose tissue sampling during surgery and urine sampling</description>
    <arm_group_label>Group &quot;Cases&quot;</arm_group_label>
    <arm_group_label>Group &quot;Controls&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        inclusion criteria :&#xD;
&#xD;
        Cases :&#xD;
&#xD;
          -  patients diagnosed with a pancreatic adenocarcinoma, all stages allowed&#xD;
&#xD;
          -  undergoing a surgery allowing to take a 10 grams adipose tissue sample&#xD;
&#xD;
        Controls :&#xD;
&#xD;
          -  patients without a pancreatic neoplasm on a 6 months old CT scan before inclusion&#xD;
&#xD;
          -  undergoing a surgery allowing to take a 10 grams adipose tissue sample&#xD;
&#xD;
        exclusion criteria :&#xD;
&#xD;
        Cases :&#xD;
&#xD;
          -  patients diagnosed with a pancreatic adenocarcinoma developed on IPMN or cystadenoma&#xD;
&#xD;
          -  patient with a known genetic predisposition increasing pancreatic adenocarcinoma risk&#xD;
&#xD;
          -  histopathology proof of a mixed neuroendocrine neoplasm&#xD;
&#xD;
          -  no surgery allowing to take a 10 grams adipose tissue sample&#xD;
&#xD;
        Controls :&#xD;
&#xD;
          -  patients with a pancreatic neoplasm on a 6 months old CT scan before inclusion&#xD;
&#xD;
          -  no surgery allowing to take a 10 grams adipose tissue sample&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olivier BOUCHE</last_name>
    <phone>03 26 78 31 13</phone>
    <phone_ext>0033</phone_ext>
    <email>obouche@chu-reims.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Damien JOLLY</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier BOUCHE</last_name>
      <phone>03 26 78 31 13</phone>
      <phone_ext>0033</phone_ext>
      <email>obouche@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 10, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Plant production products</keyword>
  <keyword>risk factor</keyword>
  <keyword>adipose tissue</keyword>
  <keyword>organochlorine</keyword>
  <keyword>pesticides</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

